Novartis deal caps Alteogen’s banner year as ALT-B4 moves into commercial era Korea Biomedical Review 5d
STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d Pharma Drugs and Alcohol Biotech
Novartis strikes $3.2 billion deal with Alteogen as drug delivery patent licences pile up IAM 4d Pharma
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore The Hindu Business Line 1d Novartis Pfizer India
AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 1d AstraZeneca FDA FTSE 100 Article paywall
Board of Sudarshan approves acquisition of 9.50% stake in MedTherapy Biotechnology Inc. The Business Standard 1d Biotechnology India
From fermentation to high containment: Indena’s integrated European platform for HPAPIs and ADC payloads Manufacturing Chemist 1d Manufacturing (UK)
